ERBB2 and cancer: Many cytoplasmic substrates of human SMYD3 have been identified, including HER2, AKT1 and MAP3K2, in various cancer types8–10, however, its nuclear function, specifically its genome-wide binding pattern and direct gene targets in human cancer cells remains largely unexplored.